Connect with us

Health

The Most Compatible Solution to the Human Body from Turkish Scientists for Joint Pains Warned by The World Health Organization!

mm

Published

on

Degeneration of the joints significantly complicates daily life.

The World Health Organization (WHO) predicts that by 2050, 130 million people worldwide will suffer from joint pain and osteoarthritis. According to the World Health Organization, by 2050, 40 million people will lose function due to osteoarthritis.

The USA is the country with the highest prevalence of osteoarthritis in the world. More than half (18.7 million people) of adults with osteoarthritis in the United States are of working age (18-64 years). For this reason, osteoarthritis also causes a significant loss of workforce.

Against joint pain and osteoarthritis Scientists have made an important discovery. Developed with hybrid technology, HYDRAVIC received full marks from health authorities.

Developed with hybrid technology and minimizing the wear on cartilage, HYDRAVIC prevents patients from complaining of pain for up to 6-8 months. Turkish scientists who developed HYDRAVIC state that patient complaints will decrease significantly.

IMPORTANT INVENTION FROM SCIENTISTS

Against joint pain and osteoarthritis, which the world is looking for a cure for, scientists have made an innovative development in intra-articular fluids. Turkish scientists have developed an intra-articular injection with the most compatible gel form with the hybrid production technology. The product, which was launched under the HYDRAVIC brand, attracts great attention all over the world.

Developed with hybrid technology and minimizing the wear on cartilage, HYDRAVIC prevents patients from complaining of pain for up to 6-8 months. Turkish scientists who developed HYDRAVIC state that patient complaints will decrease significantly.

HYDRAVIC IS VERY CLOSE TO THE HYALURONIC ACID STRUCTURE IN THE BODY

HYDRAVIC, one of the first intra-articular injections with hybrid production technology in Turkey, stands out with its patient satisfaction. Stating that HYDRAVIC minimizes the wear on the cartilage and slows down the pressure created by the body on the cartilage, Prof. Dr. Serdar Sezer said, “HYDRAVIC was developed with inspiration from the complex structure of hyaluronic acid in the body. Patient satisfaction is quite good. Hybrid technology is a system that has been applied for the first time in Turkey, like its examples in the world. HYDRAVIC prevents patients from complaining of pain for up to 6-8 months.” 

WHAT MAKES HYDRAVIC DIFFERENT IS THE DIFFERENCE OF ITS TECHNOLOGY!

Drawing attention to the importance of hybrid technology used in the production of HYDRAVIC, Professor Serdar Sezer “One of the features of hybrid technology is that it creates a triggering effect for the product to produce hyaluronic acid while being excreted from the body. This has been demonstrated in in-vitro and in-vivo experiments. Clinical long-term responses are very good. In our studies while developing these products, we have observed studies that have a longer duration of action with our innovative approach that repeats the results proven in the world. After its effectiveness has been proven, we are happy to introduce such a product to the market in the injection market, where we are one of the leading manufacturers in the field. We apply similar approaches across all our product models.” uses expressions.

Stating that they minimize the pain experienced by the patients during the injection, Professor Sezer said, “What makes HYDRAVIC different from other products is its technology. It is a product that does not make the patient feel very low or no pain during the injection and relieves the patient’s pain in a short time. In this technology, in addition to the molecular interaction, post-injection pain and swelling, etc., due to the production of the product in aseptic technical infrastructure. We minimize such complaints as possible.”

EUROPE’S LARGEST MEDICINE AND MEDICAL DEVICE R&D CENTER IS ESTABLISHED

Stating that Europe’s largest pharmaceutical and medical device R&D Center in the field of biomaterials was established in Turkey, Professor Sezer said, “To produce these kinds of products, the well-equipped infrastructures are required very serious costs. Many companies do not want to invest in such product groups, which have high infrastructure costs and are difficult to produce. With the new legislation, the costs increase significantly. We reach an annual capacity of 5.4 million units in 2023 in the HYDRAVIC production line, where we have achieved great success in the medical market.” he said.

Michelle has been a part of the journey ever since Bigtime Daily started. As a strong learner and passionate writer, she contributes her editing skills for the news agency. She also jots down intellectual pieces from categories such as science and health.

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

The Scientist as Storyteller: How Steven Quay Makes Complex Medicine Relatable

mm

Published

on

Scientific discovery often struggles to reach the people it is meant to serve. The distance between research and public understanding can be vast. For most scientists, publishing in peer-reviewed journals is the endpoint. For Dr. Steven Quay, it is only the beginning. His career has been defined not just by what he has discovered, but by how he communicates it. 

Scientific trust today faces growing skepticism and misinformation spreads faster than facts, Quay has embraced a rare role. He is both a scientist and a storyteller. His ability to bridge the technical and the human is what makes his voice resonate across disciplines, institutions, and communities.

Writing as a Lens into the Human Side of Science

One of the clearest examples of Quay’s narrative instinct lies in his writing. He has authored three major books, each rooted in a different part of his life and expertise. Together, they show how a medical researcher can also be an accessible public thinker.

In Stay Safe: A Physician’s Guide to Survive Coronavirus, published June 5, 2020, during the first days of the pandemic, Quay offered plainspoken, evidence-based guidance on protecting oneself and one’s family. It was not framed as a political statement or a policy directive. It was personal and grounded in the daily realities people faced. He wrote it not just as a scientist, but as someone who wanted to help others navigate a frightening time with clarity and calm.

His second book, The Origin of the Virus, tackled a more complex and controversial subject: the question of how SARS-CoV-2 emerged. Rather than speculate, Quay walked readers through the scientific evidence with the kind of transparency that is often lacking in public discourse. The tone was methodical, never alarmist. What set the book apart was its balance, engaging to a lay reader, yet rigorous enough to be taken seriously by professionals.

Then there is A Ride Through Northville, a deeply personal departure from the world of virology and oncology. Here, Quay revisits his childhood in Michigan, capturing the streets, friendships, and quiet moments that shaped him long before he entered a lab. The structure of the book mimics the experience of riding a bike through town, evoking memory not as a chronology, but as a sensory journey. For a scientist whose career has involved high-stakes research and global debates, this book offers a rare window into the reflective, grounded person behind the work.

Speaking Clearly Without Speaking Down

Quay’s communication skill is not limited to the written word. He has also become a frequent guest on health-focused podcasts and a speaker at public science forums. His TEDx talk on breast cancer prevention is one of the most viewed videos on the subject, and for good reason. He does not rely on drama or abstract theory. Instead, he explains mammographic density, hormonal risk, and clinical trial design in a way that makes the science both comprehensible and actionable.

In interviews, Quay has a habit of slowing things down. He avoids jargon unless he defines it. He is comfortable saying, “We don’t know yet,” which, in the realm of public science, is a kind of honesty that builds trust. He often discusses Atossa Therapeutics’ trials in plain terms, describing how experimental drugs like (Z)-endoxifen might help certain patients respond better to treatment. He emphasizes that these are ongoing studies, not marketing pitches, which sets him apart from many biotech executives.

Educating the Public Without Oversimplifying

One of the challenges of public-facing science is resisting the urge to oversimplify. Many well-intentioned scientists flatten complexity to fit the constraints of social media or mainstream news. Quay does not follow that path. He explains mechanisms and hypotheses with nuance, trusting that readers and listeners are capable of understanding more than they are often given credit for.

His social media presence reflects the same philosophy. He shares articles and research updates, but rarely with alarm or bravado. When he comments on current medical debates, he tends to lead with evidence rather than opinion. That steady tone has earned him a following that spans across ideological and professional divides.

During the pandemic, this approach stood out. While others chased headlines, Quay focused on distilling evolving guidance into practical advice. He acknowledged the limits of current knowledge, updated his views as new data emerged, and emphasized science as an iterative process. His voice became one that many people turned to not for certainty, but for clarity.

A Scientist’s Responsibility Beyond the Lab

Quay has often said that science does not exist in isolation. It is part of society. That belief informs why he writes, speaks, and engages in public discourse as actively as he does. He sees the scientist’s role not just as a producer of knowledge, but as a custodian of its meaning.

He has testified before the U.S. Congress and advised the State Department, not as a politician but as a physician-scientist committed to accuracy. In each case, his contribution has been grounded in data but shaped by a recognition of the human implications of policy and research.

This is especially evident in his work on breast cancer. By advocating for better screening tools and more personalized treatments, Quay speaks not only to clinicians and investors but to women facing real fears about their health. He explains the science behind mammographic density and hormonal modulation not just with charts, but with stories about what those risks mean in someone’s life.

Storytelling as a Form of Service

What makes Quay’s communication style compelling is that it never feels performative. He is not branding himself or building a media empire. He is doing what he believes scientists should do: make their work useful.

In every form of his storytelling, from the deeply personal to the technically specific, there is a throughline of responsibility. He understands that science touches people’s lives in ways that go far beyond the lab. For him, that means speaking clearly, writing honestly, and never underestimating the audience.

Continue Reading

Trending